An Analysis of New Approaches and Drug Formulations for Treatment of Chronic Low Back Pain
Copyright © 2017 Elsevier Inc. All rights reserved..
The prevalence of chronic low back pain (CLBP) is increasing. Treatment is effective in less than 50% of patients after 1 year. This review investigates new treatments for CLBP. An extensive literature review focuses on new treatments for CLBP. Their safety and efficacy were evaluated and are described in detail in this review. The investigation identified new treatments for CLBP including chemonucleolysis, platelet-rich plasma injections, artemin, tanezumab, and stem cells. Further research and innovation are needed to implement these methods into practice and assess clinical significance. The current evidence suggests that there are promising new agents for the treatment of CLBP.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Anesthesiology clinics - 35(2017), 2 vom: 19. Juni, Seite 341-350 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bhangare, Karishma Patel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 06.11.2017 Date Revised 08.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anclin.2017.01.023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM272084026 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM272084026 | ||
| 003 | DE-627 | ||
| 005 | 20231224234115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anclin.2017.01.023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0906.xml |
| 035 | |a (DE-627)NLM272084026 | ||
| 035 | |a (NLM)28526154 | ||
| 035 | |a (PII)S1932-2275(17)30028-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bhangare, Karishma Patel |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An Analysis of New Approaches and Drug Formulations for Treatment of Chronic Low Back Pain |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2017 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2017 Elsevier Inc. All rights reserved. | ||
| 520 | |a The prevalence of chronic low back pain (CLBP) is increasing. Treatment is effective in less than 50% of patients after 1 year. This review investigates new treatments for CLBP. An extensive literature review focuses on new treatments for CLBP. Their safety and efficacy were evaluated and are described in detail in this review. The investigation identified new treatments for CLBP including chemonucleolysis, platelet-rich plasma injections, artemin, tanezumab, and stem cells. Further research and innovation are needed to implement these methods into practice and assess clinical significance. The current evidence suggests that there are promising new agents for the treatment of CLBP | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Artemin | |
| 650 | 4 | |a Chemonucleolysis | |
| 650 | 4 | |a Chronic low back pain | |
| 650 | 4 | |a Collagenase | |
| 650 | 4 | |a Ethanol | |
| 650 | 4 | |a Matrix metalloproteinases | |
| 650 | 4 | |a Platelet-rich plasma injections | |
| 650 | 4 | |a Stem cells | |
| 650 | 4 | |a Tanezumab | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a tanezumab |2 NLM | |
| 650 | 7 | |a EQL0E9GCX1 |2 NLM | |
| 700 | 1 | |a Kaye, Alan D |e verfasserin |4 aut | |
| 700 | 1 | |a Knezevic, Nebojsa Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Candido, Kenneth D |e verfasserin |4 aut | |
| 700 | 1 | |a Urman, Richard D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anesthesiology clinics |d 2006 |g 35(2017), 2 vom: 19. Juni, Seite 341-350 |w (DE-627)NLM160807263 |x 1932-2275 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2017 |g number:2 |g day:19 |g month:06 |g pages:341-350 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anclin.2017.01.023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2017 |e 2 |b 19 |c 06 |h 341-350 | ||